November 2, 2015
At the mHealth Summit next week, MobiHealthNews is hosting a breakfast panel discussion: Digital Health's Disruption of Pharma. We'll kick things off Tuesday November 10 at 7 a.m. If you'd like to attend be sure to select the breakfast as an add-on when you register for the summit. As a thank you, use the discount code: MHEALTH50 to get 50 percent off your mHealth Summit registration.
October 2, 2015
The third quarter of 2015 was another big one for digital health, with $689 million in funding raised by 49 different companies. Read ahead for an exhaustive recap of the quarter with links to MobiHealthNews coverage of notable events throughout. If you’d prefer to navigate to a particular section, here’s where you can find our digital health news round-up section for payor news, pharma news,...
June 26, 2015
The first six months of 2015 have been chock-full of digital health news. What follows is an exhaustive recap of the first half of the year with links to MobiHealthNews coverage of notable events throughout. If you'd prefer to navigate to a particular section, here's where you can find our digital health news round-up section for payor news, pharma news, government and regulatory news, mergers...
April 15, 2015
Boston-based patient network PatientsLikeMe announced two pieces of pharma news this week: a five-year research collaboration deal with AstraZeneca and the results of a multiple sclerosis wearable study conducted in collaboration with Biogen.
The PatientsLikeMe-AstraZeneca deal is similar to one the company struck with Genentech last Spring. AstraZeneca will have full access to PatientsLikeMe's...
July 2, 2013
It turned out to be an eventful second quarter. While the first three months of 2013 were peppered with notable launches, acquisitions, and shutdowns – for the first half of Q2 not much news was shaking in digital health.
In recent weeks health plans and providers launched important data sharing initiatives; a high-profile mobile health company secured reimbursement and – perhaps more importantly...